AveXis Gene Therapy AVXS-101 Granted Access into EMA PRIME Program for Spinal Muscular Atrophy Type 1Yahoo Finance31, 2017 (GLOBE NEWSWIRE) — AveXis, Inc. (AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from … Continue reading
|
The Stem Cells In Your Investment Future
Seeking Alpha I’ll do anything to postpone aging, as regular readers of this letter already know. So, when my doctor told me she could extend the life of my knees by ten years with a stem cell injection, I was all for it. Stem cells, along with CRISPR gene editing … |
Deccan Chronicle |
Immunotherapy may revolutionise cancer treatment: expert
Deccan Chronicle The overall treatment cost of immunotherapy is presently high, but it will definitely come down, Reddy said. “Patency is there for every drug. It’s going to be minimum of one year (for cost to come down) and for some companies it is going to be two … Immunotherapy may revolutionise cancer treatment, says expertDaily News & Analysis International cancer conclave from Feb. 2The Hindu Apollo Hosp to organise conclave on cancer care from Feb 2Outlook India |
Deccan Chronicle |
Immunotherapy may revolutionise cancer treatment: expert
Deccan Chronicle The overall treatment cost of immunotherapy is presently high, but it will definitely come down, Reddy said. “Patency is there for every drug. It’s going to be minimum of one year (for cost to come down) and for some companies it is going to be two … Immunotherapy may revolutionise cancer treatment, says expertDaily News & Analysis International cancer conclave from Feb. 2The Hindu Apollo Hosp to organise conclave on cancer care from Feb 2Outlook India |